Financial reports
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 May 24
8-K
Entry into a Material Definitive Agreement
9 May 24
8-K
Entry into a Material Definitive Agreement
2 May 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Mar 24
8-K
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
22 Jan 24
8-K/A
Financial Statements and Exhibits
5 Dec 23
8-K
Entry into a Material Definitive Agreement
4 Dec 23
8-K
ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering
24 Nov 23
8-K
ELEVAI Labs, Inc. Announces Pricing of $6,000,000 Initial Public Offering
21 Nov 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
22 Nov 23
8-A12B
Registration of securities on exchange
20 Nov 23
S-1/A
IPO registration (amended)
9 Nov 23
S-1/A
IPO registration (amended)
3 Nov 23
S-1
IPO registration
28 Sep 23
D
$549.99 k in equity / options, sold $250.00 k, 2 investors
22 Sep 23
D/A
$1.60 mm in equity, sold $463.59 k, 11 investors
11 Sep 23
DRS/A
Draft registration statement (amended)
15 Aug 23
DRSLTR
Correspondence regarding draft registration statement
14 Aug 23
DRS/A
Draft registration statement (amended)
25 Jul 23
Proxies
No filings
Other
CERT
Certification of approval for exchange listing
20 Nov 23
EFFECT
Notice of effectiveness
14 Nov 23
SEC STAFF
SEC staff action: Order
13 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
SEC STAFF
SEC staff action: Order
5 Oct 23
UPLOAD
Letter from SEC
1 Aug 23
UPLOAD
Letter from SEC
14 Jul 23
UPLOAD
Letter from SEC
15 Mar 23
Ownership
SC 13G
MOA LIFE PLUS CO. LTD.
31 May 24
SC 13D
Braeden Lichti
21 Feb 24
3/A
Initial statement of insider ownership (amended)
16 Feb 24
3/A
Lichti Braeden
16 Feb 24
SC 13G
Abou-Sayed Hatem
14 Feb 24
SC 13G
Plews Jordan R.
14 Feb 24
SC 13G
JP Bio Consulting LLC
14 Feb 24
SC 13G
Hatem Abou-Sayed MD MBA FACS, a Professional Medical Corp
14 Feb 24
3
Lichti Braeden
1 Feb 24
4
Change in insider ownership
1 Feb 24